Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens

Author:  ["Yan Zheng","Patricia A Valdez","Dimitry M Danilenko","Yan Hu","Susan M Sa","Qian Gong","Alexander R Abbas","Zora Modrusan","Nico Ghilardi","Frederic J de Sauvage","Wenjun Ouyang"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

Infections by attaching and effacing (A/E) bacterial pathogens, such as Escherichia coli O157:H7, pose a serious threat to public health. Using a mouse A/E pathogen, Citrobacter rodentium, we show that interleukin-22 (IL-22) has a crucial role in the early phase of host defense against C. rodentium. Infection of IL-22 knockout mice results in increased intestinal epithelial damage, systemic bacterial burden and mortality. We also find that IL-23 is required for the early induction of IL-22 during C. rodentium infection, and adaptive immunity is not essential for the protective role of IL-22 in this model. Instead, IL-22 is required for the direct induction of the Reg family of antimicrobial proteins, including RegIIIβ and RegIIIγ, in colonic epithelial cells. Exogenous mouse or human RegIIIγ substantially improves survival of IL-22 knockout mice after C. rodentium infection. Together, our data identify a new innate immune function for IL-22 in regulating early defense mechanisms against A/E bacterial pathogens.

Cite this article

Zheng, Y., Valdez, P., Danilenko, D. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14, 282–289 (2008). https://doi.org/10.1038/nm1720

View full text

>> Full Text:   Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens

IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia

Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation